Macrophage migration inhibitory factor induces phospholamban phosphorylation in cardiac muscle
Cell Calcium · 2025
DOI: 10.1016/j.ceca.2025.103051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Calcium, 2025. Verfasst von Zihan Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan. Hauptthemen laut MEDLINE: Calcium-Binding Proteins, Macrophage Migration-Inhibitory Factors, Myocardium, Myocytes, Cardiac. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
The pleiotropic cytokine macrophage migration inhibitory factor (MIF) elevates sarcoplasmic reticulum (SR) Ca2+ content and enhances Ca2+ transient in cardiac muscle. Our imaging and immunoblot data indicated that the MIF-evoked effect is caused mainly by the phosphorylation of the SR Ca2+-pump regulator phospholamban (PLN). Gene expression data suggested that the cluster of differentiation 74 (CD74) and the C-X-C motif chemokine receptor 7 (CXCR7) form a major MIF receptor complex in cardiomyocytes, but CXCR7 activation alone seemed sufficient to exert the MIF-evoked effect. Our pharmacological assessments suggested that phosphoinositide 3-kinase (PI3K), AKT kinase and endothelial nitric oxide synthase (eNOS) were continuously stimulated in the downstream of CXCR7 activation. Furthermore, NO thus generated likely reacted to activate Ca2+/calmodulin-dependent protein kinase II (CaMKII), leading to PLN phosphorylation and subsequent SR Ca2+-pump activation. Therefore, the CXCR7-PI3K-AKT-eNOS-CaMKII-PLN axis is proposed as a central pathway for MIF-evoked potentiation of cardiac Ca2+ signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
- QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
- Department of Advanced Clinical Science and Therapeutics, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
- Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan. Electronic address: takeshim@pharm.kyoto-u.ac.jp.
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science
Zitieren
APA
Tang, Z., Liu, F., Nishi, M., Mackay, F., Harada, M., & Takeshima, H. (2025). Macrophage migration inhibitory factor induces phospholamban phosphorylation in cardiac muscle. Cell Calcium. https://doi.org/10.1016/j.ceca.2025.103051
Vancouver
Tang Z, Liu F, Nishi M, Mackay F, Harada M, Takeshima H. Macrophage migration inhibitory factor induces phospholamban phosphorylation in cardiac muscle. Cell Calcium. 2025. doi:10.1016/j.ceca.2025.103051
BibTeX
@article{Tang2025,
author = {Tang, Zihan and Liu, Feng and Nishi, Miyuki and Mackay, Fabienne and Harada, Mutsuo and Takeshima, Hiroshi},
title = {Macrophage migration inhibitory factor induces phospholamban phosphorylation in cardiac muscle},
journal = {Cell Calcium},
year = {2025},
doi = {10.1016/j.ceca.2025.103051}
}
EUVIMED